Scientific article

Gamma Scintigraphic Comparison of Eyedrops Containing Pilocarpine in Healthy Volunteers

Published inJournal of Ocular Pharmacology and Therapeutics, vol. 12, no. 4, p. 481-488
Publication date1996-01
First online date2009-01-30

The aim of the present study was to compare, in healthy human volunteers (male and female), the corneal contact time of various formulations, each containing one viscosity enhancer from the following list: a phase-transition system (gellan gum, Gelrite®), a heteropolysaccharide (xanthan gum) and currently used polymers hydroxyethylcellulose, hydroxypropylmethylcellulose, or poly(vinyl alcohol). These different solutions were compared to a reference solution containing no viscosity enhancers. The corneal contact time of the formulations was evaluated over more than 20 minutes by gamma scintigraphy using Technetium-99m (Tc-99m DTPA) as a radioactive label. An eyedrop containing pilocarpine salts (25μl) was instilled in one eye only. Each volunteer received 4 formulations, the interval between the instillations being one week. The protocol has been approved by the relevant institutional human experimentation committee. One minute after instillation, only 23% of the reference solution remained on the ocular surface, whereas the novel formulations maintained, respectively, 77% (xanthan gum) or 82% (Gelrite®) of the tracer on the ocular surface. Twenty-one min after instillation, 12% (reference solution), 25% (xanthan gum solution), and 39% (gelrite solution) of the tracer remained on the ocular surface. The results confirm that an increase in viscosity of the formulation (xanthan) delays the clearance of the instilled solution by the tear flow. The effect of the gelation mechanism is superior, especially at the later time points. In this respect, xanthan gum and, particularly, Gelrite® are suitable vehicles for ophthalmic drags.

Citation (ISO format)
MESEGUER, Georges Manuel et al. Gamma Scintigraphic Comparison of Eyedrops Containing Pilocarpine in Healthy Volunteers. In: Journal of Ocular Pharmacology and Therapeutics, 1996, vol. 12, n° 4, p. 481–488. doi: 10.1089/jop.1996.12.481
Main files (1)
Article (Published version)
ISSN of the journal1080-7683

Technical informations

Creation12/22/2022 10:00:00 AM
First validation12/22/2022 10:00:00 AM
Update time03/16/2023 10:18:37 AM
Status update03/16/2023 10:18:36 AM
Last indexation08/31/2023 10:19:54 AM
All rights reserved by Archive ouverte UNIGE and the University of GenevaunigeBlack